robert kennedy glp 1 RFK Jr. considering 'framework' for Medicaid, Medicare coverage of GLP-1s Health Secretary Robert F. Kennedy
Description
Participants received diet (500kcaldeficit per day) and exercise counseling during 2-week run-in, before being randomly assigned (with a telephone or web-based system) to once-daily subcutaneous liraglutide (1.2, 1.8, 2.4 or 3.0mg, n=9095), placebo (n=98) or open-label orlistat (120mg 3, n=95)
Support blood sugar, appetite, and weightno meds required.
GLP-1 Patent Expiry: The Next Big Pharma Race Has Already Begun GLP-1 agonists like semaglutide, tirzepatide, and liraglutide have completely reshaped the global diabetes and obesity landscape
Until today, the answer was a mystery
Diabetes Obes Metab
